The article offers information on long QT syndrome, a medical condition in which the heart's electrical activity is longer than normal following a heartbeat. Topics discussed include the causes of the syndrome, medications such as beta blockers, and medical devices such as implantable cardioverter-...
8 ⅐ No. 3 review The long QT syndrome family of cardiac ion channelopathies: A HuGE review* Stephen M. Modell, MD, MS1, and Michael H. Lehmann, MD2 Long QT syndrome (LQTS) refers to a group of "channelopathies"– disorders that affect cardiac ion channels. The "family" concept ...
“Our results refine and improve the diagnostic ability of treadmill stress test during the evaluation of patients with possiblelong QT syndromeby showing precisely where the greatest diagnostic separation resides, the recovery phase,...
Figure 2. Performance of a Convolutional Neural Network (CNN) in Long QT Syndrome (LQTS) Detection View LargeDownload Receiver operating characteristic curves and confusion matrices for LQTS detection analyses showing results of CNN performance on the patient’s first Mayo Clinic electrocardiogram (ECG)...
Inferring Long QT1 Genotype Based on a Simple Epinephrine Infusion Protocol: From the Bedside to the Bench and Back Comment on Mayo Clin Proc. 2002 May;77(5):413-21. Perry,C James - 《Mayo Clinic Proceedings》 被引量: 2发表: 2002年 Effect of verapamil in the treatment of type 2 lon...
The article offers the authors perspective on the use of genetic testing for long QT syndrome (LQTS) in suspected sudden unexplained cardiac death (SUD) by medical examiners (ME). The authors is critical on the barriers of genetic testing for CCs such as cost and the ability of medical exami...
“Building on our previous work using Mayo Clinic’s proprietary T-wave fingerprint software, it is stunning that our ‘AI brain’ is distinguishing one patient who has a potentially life-threatening syndrome, [long QT syndrome], but a normal...
Since May 2004, genetic testing has been available as a clinical diagnostic test from Genaissance Pharmaceuticals IPR (now Clinical Data, Inc.).[1]According to Dr. Ackerman, Director of the Long QT Syndrome Clinic and Sudden Death Genomics Laboratory at Mayo Clinic, it is now critical to caref...
International guidelines advise universal beta-blocker therapy as either a class I (symptomatic or QTc ≥470 ms) or class II (asymptomatic and QTc <470 ms) recommendation for treatment of long QT syndrome (LQTS). Objective The purpose of this study was to evaluate the outcomes of a highly se...
Participation in competitive sports by people with long QT syndrome -- a genetic abnormality in the heart's electrical system -- has been a matter of debate among physicians. Current guidelines disqualify most LQTS patients from almost every sport. In a first-of-its-kind study, Mayo Clinic's...